Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.

To evaluate the roles of iatrogenic hypoglycemia and diabetes per se in the pathogenesis of defective hormonal counterregulation against hypoglycemia in insulin-dependent diabetes mellitus (IDDM), nondiabetic, and spontaneously diabetic BB/Wor rats were studied using a euglycemic/hypoglycemic clamp. In nondiabetic rats, recurrent (4 wk) insulin-induced hypoglycemia (mean daily glucose, MDG, 59 mg/dl) dramatically reduced glucagon and epinephrine responses by 84 and 94%, respectively, to a standardized glucose fall from 110 to 50 mg/dl. These deficits persisted for > 4 d after restoring normoglycemia, and were specific for hypoglycemia, with normal glucagon and epinephrine responses to arginine and hypovolemia, respectively. After 4 wk of normoglycemia, hormonal counterregulation increased, with the epinephrine, but not the glucagon response reaching control values. In diabetic BB rats (MDG 245 mg/dl with intermittent hypoglycemia), glucagon and epinephrine counterregulation were reduced by 86 and 90%, respectively. Chronic iatrogenic hypoglycemia (MDG 52 mg/dl) further suppressed counterregulation. Prospective elimination of hypoglycemia (MDG 432 mg/dl) improved, but did not normalize hormonal counterregulation. In diabetic rats, the glucagon defect appeared to be specific for hypoglycemia, whereas deficient epinephrine secretion also occurred during hypovolemia. We concluded that both recurrent hypoglycemia and the diabetic state independently lead to defective hormonal counterregulation. These data suggest that in IDDM iatrogenic hypoglycemia magnifies preexisting counterregulatory defects, thereby increasing the risk of severe hypoglycemia.

[1]  A. Cherrington,et al.  Effects of differing insulin levels on response to equivalent hypoglycemia in conscious dogs. , 1992, The American journal of physiology.

[2]  P. Cryer.  Iatrogenic Hypoglycemia as a Cause of Hypoglycemia-Associated Autonomic Failure in IDDM: A Vicious Cycle , 1992, Diabetes.

[3]  H. Shamoon,et al.  Counterregulatory adaptation to recurrent hypoglycemia in normal humans. , 1991, The Journal of clinical endocrinology and metabolism.

[4]  E. Moberg,et al.  A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. , 1991, The Journal of clinical endocrinology and metabolism.

[5]  S. Amiel.  Glucose counter-regulation in health and disease: current concepts in hypoglycaemia recognition and response. , 1991, The Quarterly journal of medicine.

[6]  D. Kerr,et al.  Importance of Insulin in Subjective, Cognitive, and Hormonal Responses to Hypoglycemia in Patients With IDDM , 1991, Diabetes.

[7]  T. Jones,et al.  Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. , 1991, The Journal of clinical endocrinology and metabolism.

[8]  D. Simonson,et al.  Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. , 1990, Annals of internal medicine.

[9]  P. Cryer,et al.  Hypoglycemia in IDDM , 1989, Diabetes.

[10]  A. Cooke,et al.  Distinct Macrophage Subpopulations in Pancreas of Prediabetic BB/E Rats: Possible Role for Macrophages in Pathogenesis of IDDM , 1988, Diabetes.

[11]  W. Tamborlane,et al.  Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release , 1988, Diabetes.

[12]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[13]  W. Tamborlane,et al.  Hypoglycemia and glucose counterregulation in normal and insulin-dependent diabetic subjects. , 1988, Diabetes/metabolism reviews.

[14]  W. Tamborlane,et al.  Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. , 1987, The New England journal of medicine.

[15]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.

[16]  H. Shamoon,et al.  Defective Epinephrine and Growth Hormone Responses in Type I Diabetes Are Stimulus Specific , 1987, Diabetes.

[17]  R. DeFronzo,et al.  Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. , 1985, Annals of internal medicine.

[18]  P. Cryer,et al.  Defective glucose counterregulation limits intensive therapy of diabetes mellitus. , 1984, The American journal of physiology.

[19]  P. Cryer,et al.  Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans. , 1984, The American journal of physiology.

[20]  J. Logothetopoulos,et al.  The Onset and Progression of Pancreatic Insulitis in the Overt, Spontaneously Diabetic, Young Adult BB Rat Studied by Pancreatic Biopsy , 1984, Diabetes.

[21]  P. Brunetti,et al.  The Adrenergic Contribution to Glucose Counterregulation in Type I Diabetes Mellitus: Dependency on A-Cell Function and Mediation Through Beta2-Adrenergic Receptors , 1983, Diabetes.

[22]  P. Cryer,et al.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. , 1983, The New England journal of medicine.

[23]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[24]  K. Polonsky,et al.  Relation of counterregulatory responses to hypoglycemia in type I diabetics. , 1982, The New England journal of medicine.

[25]  P. Brunetti,et al.  Important Role of Adrenergic Mechanisms in Acute Glucose Counterregulation Following Insulin-induced Hypoglycemia in Type I Diabetes: Evidence for an Effect Mediated by Beta-Adrenoreceptors , 1982, Diabetes.

[26]  R. Unger.  Special Comment: Meticulous Control of Diabetes: Benefits, Risks, and Precautions , 1982, Diabetes.

[27]  P. Cryer,et al.  Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. , 1982, The Journal of clinical investigation.

[28]  T. Seemayer,et al.  Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. II. Insulin-, glucagon-, and somatostatin-reactive cells in the pancreas. , 1981, Endocrinology.

[29]  Y. Yamasaki,et al.  Perfect Normalization of Excessive Glucagon Responses to Intravenous Arginine in Human Diabetes Mellitus With the Artificial Beta-Cell , 1980, Diabetes.

[30]  L. Orci,et al.  Elevated Portal and Peripheral Blood Concentration of Immunoreactive Somatostatin in Spontaneously Diabetic (BBL) Wistar Rats: Suppression With Insulin , 1980, Diabetes.

[31]  E. Marliss,et al.  The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome. , 1978, Diabetologia.

[32]  A. Katz,et al.  Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat. , 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[33]  E. Marliss,et al.  The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies , 1977, Diabetes.

[34]  E. Tsalikian,et al.  Effects of Acute Insulin Withdrawal and Administration on Plasma Glucagon Responses to Intravenous Arginine in Insulin-dependent Diabetic Subjects , 1976, Diabetes.

[35]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.

[36]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[37]  A. Renold,et al.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response. , 1969, The Journal of clinical investigation.